Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further growth in 2025.

US stocks fell Thursday as trading resumed after the Christmas holiday, as Wall Street digested one of the only significant economic data points of the week. Meanwhile, bitcoin (BTC-USD) slumped, ...

Dan Dick, owner of three Melbourne cafes, said while it might be tough for consumers to pay a surcharge, it's much harder for ...

Getting an unwanted gift can be tricky but personal finance expert Sarah Megginson said there are a few options to get around the issue.

Aussies lost a record amount of money to cybercriminals this year and experts have warned about the emerging scams to be ...

The Australian Defence Force is hiring nuclear submarine officers and said no experience is required for the job.

"A review of the 24-hour Medicare program and Medicare telephone claims lines found they have an exceptionally low call ...

Nvidia will no doubt have the biggest CES 2025. Companies like OpenAI and Meta have purchased Nvidia processors by the ...

OneFirm Approach Delivering Results - Drives Increased Revenue, Reduced Expenses, and Growing EBITDA Spetner Acquisition Nears Final Stages, Strengthening Company’s Future Prospects LAKEWOOD, N.J., ...

D Systems trades at $3.53 and has moved in lockstep with the market. Its shares have returned 8% over the last six months ...

Failed to fetch dynamically imported module: https://au.finance.yahoo.com/assets/_app/immutable/nodes/2.DFAxXzO-.js ...

The government wants to bring in a new cash law by 2026 and wants to hear from everyone passionate about the topic.